Abbott Q3 revenue edges past estimates as company keeps full-year guidance
Abbott Laboratories reported Q3 2026 revenue of $13.01 billion, up 14.5%, and adjusted EPS of $1.42, and reaffirmed its full-year outlook.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, citing an SEC filing, and Reuters, Abbott Laboratories posted third-quarter 2026 net sales of $13.01 billion, up 14.5% from a year earlier. Analyst consensus sat near $13 billion, so the result only slightly exceeded it. Adjusted diluted EPS came in at $1.42, in line with expectations, while GAAP EPS was $0.53.
The company reaffirmed its full-year 2026 outlook, with adjusted diluted EPS of $5.50 to $5.55 and comparable sales growth of about 6.0%. For the fourth quarter, Abbott projects adjusted diluted EPS of $1.62 to $1.67.
why it matters
The key point for markets is steady growth: revenue came in a touch above forecasts, and keeping the annual outlook signals management confidence. Much of the diagnostics growth reflects the Exact Sciences acquisition, completed on March 23, 2026, along with higher Cologuard sales. Reuters reports that the average analyst rating on the shares is buy, with a median 12-month price target of $120.50 versus an October 20 close of $102.45.
market impact
Medical devices: a solid report and reaffirmed guidance support Abbott shares and the sector.
tags
instruments
sources
- Abbott Laboratories Q3 2026: Revenue $13.01B, Adjusted EPS $1.42; Reaffirms FY Guidance — TradingView, 21 October 2026 at 11:43 UTC
- Abbott's Q3 revenue slightly beats estimates, reaffirms adjusted EPS guidance — Reuters, 21 October 2026 at 11:41 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗